Skip to content
Open access · CC-BY via OpenAlex

GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective

Ramu Adela, S. Banerjee

Journal of Diabetes Research · 2015 · ▲ 472 citations

Abstract

Growth differentiation factor-15 (GDF-15) is a stress responsive cytokine. It is highly expressed in cardiomyocytes, adipocytes, macrophages, endothelial cells, and vascular smooth muscle cells in normal and pathological condition. GDF-15 increases during tissue injury and inflammatory states and is associated with cardiometabolic risk. Increased GDF-15 levels are associated with cardiovascular diseases such as hypertrophy, heart failure, atherosclerosis, endothelial dysfunction, obesity, insulin resistance, diabetes, and chronic kidney diseases in diabetes. Increased GDF-15 level is linked with the progression and prognosis of the disease condition. Age, smoking, and environmental factors are other risk factors that may increase GDF-15 level. Most of the scientific studies reported that GDF-15 plays a protective role in different tissues. However, few reports show that the deficiency of GDF-15 is beneficial against vascular injury and inflammation. GDF-15 protects heart, adipose tissue, and endothelial cells by inhibiting JNK (c-Jun N-terminal kinase), Bad (Bcl-2-associated death promoter), and EGFR (epidermal growth factor receptor) and activating Smad, eNOS, PI3K, and AKT signaling pathways. The present review describes the different animal and clinical studies and patent updates of GDF-15 in diabetes and cardiovascular diseases. It is a challenge for the scientific community to use GDF-15 information for patient monitoring, clinical decision-making, and replacement of current treatment strategies for diabetic and cardiovascular diseases.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1155/2015/490842
Canonical
link ↗
Fetched
2026-07-28 MST

Cite this

APA
Adela, R., &amp; Banerjee, S. (2015). GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective. <em>Journal of Diabetes Research</em>. https://doi.org/10.1155/2015/490842
Vancouver
Adela R, Banerjee S. GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective. Journal of Diabetes Research. 2015. doi:10.1155/2015/490842.
BibTeX
@article{ramu2015GDFasa, title = {GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective}, author = {Ramu Adela and S. Banerjee}, journal = {Journal of Diabetes Research}, year = {2015}, doi = {10.1155/2015/490842}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings